- Home
- RECT vs IGC Comparison
RECT vs IGC Comparison
Compare RECT & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RECT | IGC |
|---|---|---|
| Founded | 1997 | 2005 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.1M | 28.5M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | RECT | IGC |
|---|---|---|
| Price | $1.67 | $0.29 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.13 |
| AVG Volume (30 Days) | 8.6K | ★ 465.2K |
| Earning Date | 02-20-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $32,594,177.00 | $1,106,000.00 |
| Revenue This Year | N/A | $3.54 |
| Revenue Next Year | N/A | $15.12 |
| P/E Ratio | $14.35 | ★ N/A |
| Revenue Growth | ★ 5.91 | N/A |
| 52 Week Low | $1.50 | $0.25 |
| 52 Week High | $6.43 | $0.50 |
Technical Indicators
Market Signals| Indicator | RECT | IGC |
|---|---|---|
| Relative Strength Index (RSI) | 43.09 | 46.13 |
| Support Level | $1.58 | $0.29 |
| Resistance Level | $1.90 | $0.31 |
| Average True Range (ATR) | 0.10 | 0.01 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 30.82 | 37.71 |
Price Performance
Historical ComparisonAbout RECT Rectitude Holdings Ltd
Rectitude Holdings Ltd is principally involved in the provision of safety equipment, encompassing essential items such as personal protective clothing, hand gloves, safety footwear, and personal fall arrest systems (a system used to arrest an employee in a fall from a walking-working surface, usually consisting of a body harness, anchorage, and connector), portable fire extinguishers and traffic products such as rubber speed humps, wheel stops and wheel chocks. Additionally the company has added auxiliary products such as industrial hardware tools and electrical hardware required for construction sites.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.